Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

926
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
926
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.7K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.7K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

2.2K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the barriers to optimal survivorship care for people living with Cancer in NSW.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Preoperative Risk Evaluation for Cancer Treatment (PREdiCT): protocol for an international cohort study evaluating a trimodal screening tool to predict outcomes following gastrointestinal cancer surgery.

BMJ open·2026
Same author

The Multinational Association for Supportive Care in Cancer work after cancer global challenges and solutions white paper: key findings and recommendations.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Cancer and Ageing Reflections for Elders (CARE): Australian Adaptation of a Psychotherapy for Older Adults With Cancer.

Psycho-oncology·2026
Same author

A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol.

PloS one·2026
Same author

SUN-SHINE Sarcoma Systematic Environmental Scan: Evaluation of the Readability, Understandability, and Actionability of Websites Supporting Patients Diagnosed With Sarcoma and Their Caregivers.

Psycho-oncology·2025
Same journal

Integrated analysis of nutrition profiles and dried blood spot proteomics reveals patterns associated with autism spectrum disorder.

Nutritional neuroscience·2026
Same journal

Association between ultra-processed food intake, depression risk and quality of life in community-dwelling older adults.

Nutritional neuroscience·2026
Same journal

Healthy-Unhealthy food group balance and cognitive performance in Chilean adolescents: a canonical correlation analysis - The Cogni-Action Project.

Nutritional neuroscience·2026
Same journal

Microbial modulation of CNS remyelination in multiple sclerosis: the missing link in gut-brain axis research.

Nutritional neuroscience·2026
Same journal

Dietary habits and olfactory function in individuals with Parkinson's disease: an underexplored association.

Nutritional neuroscience·2026
Same journal

A review on thymoquinone: a promising therapeutic molecule in Alzheimer's.

Nutritional neuroscience·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.0K

Nicotinamide and neurocognitive function.

George Rennie, Andrew C Chen, Haryana Dhillon

    Nutritional Neuroscience
    |February 25, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Nicotinamide (vitamin B3) shows promise for improving cognitive function. Research suggests this inexpensive nutrient may help preserve and enhance brain health, warranting further human studies.

    Keywords:
    MemoryNiacinamideVitamin B3

    More Related Videos

    Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
    10:48

    Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine

    Published on: January 25, 2019

    10.6K
    Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
    10:04

    Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

    Published on: October 29, 2012

    19.3K

    Related Experiment Videos

    Last Updated: May 2, 2026

    A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
    07:02

    A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

    Published on: February 11, 2019

    10.0K
    Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
    10:48

    Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine

    Published on: January 25, 2019

    10.6K
    Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
    10:04

    Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

    Published on: October 29, 2012

    19.3K

    Area of Science:

    • Biochemistry
    • Neuroscience
    • Nutritional Science

    Background:

    • Nicotinamide (vitamin B3) is a NAD(+) precursor vital for cellular energy and responses.
    • NAD(+) is essential for ATP production, fueling cellular functions.
    • Nicotinamide's potential neuroprotective effects have been explored in various study models.

    Purpose of the Study:

    • To review existing evidence on nicotinamide's impact on cognitive function.
    • To assess nicotinamide as a preventive and therapeutic agent for neurocognitive disorders.

    Main Methods:

    • Conducted a literature review of studies on nicotinamide and cognitive function.
    • Examined research on age-related cognitive decline, Alzheimer's, Parkinson's, and brain injuries.
    • Included animal, human interventional, and epidemiological data.

    Main Results:

    • Evidence from animal and human studies suggests nicotinamide may benefit cognitive function.
    • Nicotinamide shows potential in preserving and enhancing neurocognitive performance.
    • Data indicates a positive association between nicotinamide and brain health.

    Conclusions:

    • Nicotinamide is a safe, affordable, and accessible nutrient.
    • Further human interventional studies with supplemental nicotinamide are recommended.
    • Nicotinamide holds potential for supporting cognitive health across various conditions.